19 results
IDSA - Prophylaxis to Prevent First Episode of Opportunistic Disease in HIV-AIDS
 • Pneumocystis pneumonia (PCP)
IDSA - Prophylaxis ... Opportunistic Disease ... complex (MAC) disease ... Infections #OIs #HIVAIDS ... #IDSA #management
IDSA - Prophylaxis to Prevent First Episode of Opportunistic Disease in HIV-AIDS
 • Pneumocystis pneumonia (PCP)
IDSA - Prophylaxis ... Opportunistic Disease ... complex (MAC) disease ... Infections #OIs #HIVAIDS ... #IDSA #management
COVID-19: ICU Guidelines for the Non-Intensivist
Infection Control
Risk Factors for Severe Disease
Initial Laboratory Workup
COVID-19 Specific Medications
Respiratory
Cardiac
Hematologic
Neuro/Sedation

#COVID19 #ICU
COVID-19: ICU Guidelines ... Factors for Severe Disease ... Laboratory Workup COVID ... #ICU #criticalcare ... NonIntensivist #diagnosis #management
Ivermectin. Old anti-parasitic agent making a comeback with recent headlines from in-vitro study that showed antiviral
SARS-CoV-2, the virus ... causing COVID-19 ... ivermectin… #COVID19 ... InfectiousDiseases #CriticalCare ... #Antiviral #Management
Proposed Respiratory Support Algorithm in COVID19

The ‘intubate early’ paradigm, where patients who “fail” low flow oxygen
Support Algorithm in COVID19 ... lung disease are ... this may be the disease ... #management #schema ... #criticalcare #
COVID-19 - A Seattle Intensivist's One-Page Cheat-Sheet on COVID-19 v2.7 Updated March 26 2020

(v2.7) incorporating newer
Nomenclature (NOT "Wuhan Virus ... Infection: Coronavirus Disease ... COVID-19 • Virus ... Cheatsheet #Diagnosis #Management ... #Coronavirus #CriticalCare
IDSA Recommendations for Preventing and Treating Chagas Disease (American Trypanosomiasis) in HIV-AIDS
Preventing Clinical Disease
Indication:  Individuals
IDSA Recommendations ... Treating Chagas Disease ... Trypanosomiasis #IDSA ... Prevention #Treatment #management ... opportunistic #infections #HIVAIDS
IDSA Treatment Recommendations for Cryptococcal Meningoencephalitis in Human Immunodeficiency Virus Infected Individuals
Induction therapy:
 • AmBd (0.7–1.0
IDSA Treatment Recommendations ... Immunodeficiency Virus ... Meningoencephalitis #IDSA ... #Treatment #management ... #cryptococcus #HIVAIDS
IDSA Recommendations for Treating Herpes Simplex Virus (HSV) Infections in HIV-AIDS
Treating Orolabial Lesions (Duration: 5–10 days)
IDSA Recommendations ... Herpes Simplex Virus ... HerpesSimplex #HSV #IDSA ... Prevention #Treatment #management ... opportunistic #infections #HIVAIDS
IDSA Recommendations for Preventing and Treating Varicella Zoster Virus (VZV) Infections in HIV-AIDS
Pre-Exposure Prevention of VZV
IDSA Recommendations ... confirmation of disease ... #Zoster #VZV #IDSA ... Prevention #Treatment #management ... opportunistic #infections #HIVAIDS